Timeline
Cathie Wood says AI and five-platform convergence could sharply lift global growth
Why Samsung is paying $1.8 billion for a Swiss peptide maker nobody's heard of
Heart drug failure casts doubt on a whole class of medicines
Likang Life Sciences to open China’s first AI-assisted personalised cancer vaccine line in Beijing
AI-designed vaccine could protect against entire virus families
REPLIQA joins a crowded field betting that quantum computing can crack biology, but the science is further along than...
Mirror bacteria: the lab-made microbes scientists now fear could threaten all life on Earth
Amazon launches Bio Discovery AI for drug research
ONCOMATRYX raises $67m for Quantum ADC clinical trials
Roche deploys 3,500 NVIDIA Blackwell GPUs to embed AI across drug discovery and manufacturing
Microsoft trains AI model to convert standard pathology slides into protein maps
Google unveils new Gemini and Nano Banana model updates
Lilly inaugurates LillyPod AI supercomputer to accelerate drug discovery in Indianapolis
Palantir Beats The Street As It Upgrades Its Outlook
Microsoft researcher says AI is learning the language of biology
Biobeat Technologies raises $50 million to accelerate US rollout of cuff-less blood pressure monitor
Longevity boom reshapes investment outlook as ageing populations stay healthier for longer
Novo Nordisk launches Wegovy pill as knownwell joins NovoCare network
Bayer partners with Cradle to deploy AI platform across antibody research
Chai Discovery partners with Eli Lilly to accelerate biologics design with AI
Multiply Labs uses robotics and NVIDIA simulation to scale cell therapy manufacturing
NVIDIA expands BioNeMo platform as pharma groups commit up to $1bn to AI-driven drug discovery
Biological age tests explained: What they measure, what they miss, and how to read the results
Lab-on-a-chip explained: Tiny microfluidic devices that could shrink the laboratory
Digital twins in medicine and engineering: How to tell a useful tool from an expensive mirage
CRISPR delivery explained: Why editing DNA is easier than getting the editor to the right cells
Biofoundries explained: Inside the robot labs, engineering biology at industrial scale
New antibiotics explained: Phages, bacteriocins and AI, and why none is a silver bullet
The quiet revolution in protein design: Enzymes and binders made by algorithms, built in yeast
Organoids on a chip: Miniature human tissues that are changing how drugs are tested
Living medicines, strange ethics: the rise of engineered microbes that treat disease from the inside
The cell’s postal service: How extracellular vesicles could become the next drug delivery revolution
CRISPR’s next act: Editors that rewrite single letters without cutting the DNA
Batteries, not brains: Bioelectricity and the new map of how bodies heal
The immune system’s new teachers: Personalised cancer vaccines and the logistics of made-to-order medicine
The end of antibiotics, again: phage therapy, bacteriocins, and precision antimicrobials
Biology’s new supply chains: Why the future of biotech may be manufacturing, not discovery
Google.org awards $20m to AI-led science projects tackling health, energy and biodiversity
10X Health and Verséa unveil mitochondrial test developed from NASA research
HBO Max unveils February slate of originals, films and live sports
MoltBot Explained: The viral AI agent formerly ClawdBot
Hims & Hers to air national Big Game ad highlighting healthcare access gap
Eli Lilly to build $3.5bn weight-loss drug facility in Pennsylvania
Nvidia signals record OpenAI investment while distancing itself from $100bn figure
First human trial of cellular reprogramming approved in bid to treat blindness
Helus Pharma looks to lead a new approach to treating depression
Pfizer’s new weight-loss drug may offer monthly alternative to Wegovy and Mounjaro
BrainChild project builds precision cancer treatment platform for children in Sweden
Novo Nordisk's terrible week reveals the brutal economics of the obesity drug gold rush
More in AI
Google's September 2026 spam update: what it is, who it hits and what Google is trying to fix
The latest Google spam update is the September 2026 spam update, which Google released at 09:15 US Pacific time on 24 September 2026 and which is still rolling out as of 28 September; it adds no new policy and does not target AI content as such, but it strengthens the automated systems that punish content made at scale to manipulate rankings.